参考文献/References:
[1] Kanashiro-Takeuchi RM,Schulman IH,Hare JM.Pharmacologic and genetic strategies to enhance cell therapy for cardiac regeneration[J].J Mol Cell Cardiol,2011,51(4):619-625.
[2] Iglesias-Garcia O,Pelacho B,Prosper F.Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling[J].J Mol Cell Cardiol,2013,62:43-50.
[3] Makridakis M,Roubelakis MG,Vlahou A.Stem cells: insights into the secretome[J].Biochim Biophys Acta,2013,1834(11):2380-2384.
[4] Ailawadi S,Wang X,Gu H,et al.Pathologic function and therapeutic potential of exosomes in cardiovascular disease[J].Biochim Biophys Acta,2015,1852(1):1-11.
[5] Huang L,Ma W,Ma Y,et al.Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases?[J].Int J Biol Sci,2015,11(2):238-245.
[6] Kurpinski K,Lam H,Chu J,et al.Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells[J].Stem Cells,2010,28(4):734-742.
[7] Dufourcq P,Descamps B,Tojais NF,et al.Secreted frizzled-related protein-1 enhances mesenchymal stem cell function in angiogenesis and contributes to neovessel maturation[J].Stem Cells,2008,26(11):2991-3001.
[8] Tang YL,Zhao Q,Qin X,et al.Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction[J].Ann Thorac Surg,2005,80(1):229-236, 236-237.
[9] Arslan F,Lai RC,Smeets MB,et al.Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury[J].Stem Cell Res,2013,10(3):301-312.
[10] Feng Y,Huang W,Wani M,et al.Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22[J].PLoS One,2014,9(2):e88685.
[11] Yu B,Gong M,Wang Y,et al.Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles[J].PLoS One,2013,8(8):e73304.
[12] Kang K,Ma R,Cai W,et al.Exosomes secreted from CXCR4 overexpressing mesenchymal stem cells promote cardioprotection via Akt signaling pathway following myocardial infarction[J].Stem Cells Int,2015,2015:659890.
[13] Salomon C,Ryan J,Sobrevia L,et al.Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis[J].PLoS One,2013,8(7):e68451.
[14] Lopatina T,Bruno S,Tetta C,et al.Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential[J].Cell Commun Signal,2014,12:26.
[15] Zhao Y,Sun X,Cao W,et al.Exosomes derived from human umbilical cord mesenchymal stem cells relieve acute myocardial ischemic injury[J].Stem Cells Int,2015,2015:761643.
[16] Bian S,Zhang L,Duan L,et al.Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model[J].J Mol Med(Berl),2014,92(4):387-397.
[17] Sanada S,Komuro I,Kitakaze M.Pathophysiology of myocardial reperfusion injury:preconditioning, postconditioning, and translational aspects of protective measures[J].Am J Physiol Heart Circ Physiol,2011,301(5):H1723-H1741.
[18] Balmer GM,Riley PR.Harnessing the potential of adult cardiac stem cells: lessons from haematopoiesis, the embryo and the niche[J].J Cardiovasc Transl Res,2012,5(5):631-640.
[19] Sahoo S,Klychko E,Thorne T,et al.Exosomes from human CD34(+)stem cells mediate their proangiogenic paracrine activity[J].Circ Res,2011,109(7):724-728.
[20] Mackie AR,Klyachko E,Thorne T,et al.Sonic hedgehog-modified human CD34+ cells preserve cardiac function after acute myocardial infarction[J].Circ Res,2012,111(3):312-321.
[21] Vrijsen KR,Sluijter JP,Schuchardt MW,et al.Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells[J].J Cell Mol Med,2010,14(5):1064-1070.
[22] Barile L,Lionetti V,Cervio E,et al.Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction[J].Cardiovasc Res,2014,103(4):530-541.
[23] Chen L,Wang Y,Pan Y,et al.Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury[J].Biochem Biophys Res Commun,2013,431(3):566-571.
[24] Gray WD,French KM,Ghosh-Choudhary S,et al.Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology[J].Circ Res,2015,116(2):255-263.
[25] Smith RR,Barile L,Cho HC,et al.Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens[J].Circulation,2007,115(7):896-908.
[26] Cheng K,Malliaras K,Smith RR,et al.Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair[J].JACC Heart Fail,2014,2(1):49-61.
[27] Khan M,Nickoloff E,Abramova T,et al.Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction[J].Circ Res,2015,117(1):52-64.
[28] Wang Y,Zhang L,Li Y,et al.Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium[J].Int J Cardiol,2015,192:61-69.
[29] Emanueli C,Shearn AI,Angelini GD,et al.Exosomes and exosomal miRNAs in cardiovascular protection and repair[J].Vascul Pharmacol,2015,71:24-30.
相似文献/References:
[1]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(2):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[2]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(2):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[3]张伟 木胡牙提.外泌体源性miRNAs在心血管疾病中的研究进展[J].心血管病学进展,2020,(2):111.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.002]
Zhang Wei,Muhuyati.Exogenous miRNAs in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(2):111.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.002]
[4]李一凡 张智伟.巨噬细胞相关的外泌体在心血管疾病中的作用研究进展[J].心血管病学进展,2020,(8):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
LI Yifan,ZHANG Zhiwei.Role of Macrophage-Related Exosomes in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(2):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
[5]叶莎 杨翠玲 郑媛媛.骨髓间充质干细胞来源外泌体通过PI3K/Akt途径减轻H2O2诱导心肌细胞损伤[J].心血管病学进展,2022,(3):269.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
YE Sha,YANG Cuiling,ZHENG Yuanyuan.Bone Marrow Mesenchymal Stem Cells Derived Exosomes Attenuate H 2O2 Induced Cardiomyocyte Injury Via PI3K/Akt Pathway[J].Advances in Cardiovascular Diseases,2022,(2):269.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[6]肖轶 余国龙.不同干细胞来源的外泌体在缺血性心脏病中的促血管新生作用[J].心血管病学进展,2022,(4):293.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.002]
XIAO Yi,YU Guolong?/html>.Application of Exosomes Derived from Various Stem Cells?n Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2022,(2):293.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.002]
[7]俞佳丽 景雨 张剑 陈楚 陆齐 顾周山 陈子微 周大胜 景宏美 潘丽华.间充质干细胞来源的外泌体在心肌梗死治疗中的研究进展[J].心血管病学进展,2022,(4):341.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.013]
YU JialiJING YuZHANG JianCHEN ChuLU QiGU ZhoushanCHEN ZiweiZHOU DashenJING HongmeiPAN Lihua.Exosomes Derived from Mesenchymal Stem Cells?n the Treatment of Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(2):341.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.013]
[8]杨珂欣 李星辉 肖晨朦 姚晓涛 林萌 蔡佳.间充质干细胞来源外泌体改善心肌纤维化的研究进展[J].心血管病学进展,2022,(12):1123.[doi:10.16806/j.cnki.issn.1004-3934.20.10.015]
YANG Kexin LI Xinghui XIAO ChenmengYAO XiaotaoLIN MengCAI Jia.Improving Myocardial Fibrosis by Exosome Derived from Mesenchymal Stem Cell[J].Advances in Cardiovascular Diseases,2022,(2):1123.[doi:10.16806/j.cnki.issn.1004-3934.20.10.015]
[9]陈鹏莉 宋紫微 张曼玉 李丽丽.干细胞来源外泌体miRNA介导心脏修复的研究进展[J].心血管病学进展,2023,(7):636.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.014]
CHEN Pengli,SONG Ziwei,ZHANG Manyu,et al.Exosomal miRNA Derived from Stem Cells in Mediating Cardiac Repair[J].Advances in Cardiovascular Diseases,2023,(2):636.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.014]
[10]杨安妮 厉腊梅 王绿娅 蔡高军.外泌体与脂质代谢研究进展[J].心血管病学进展,2024,(8):753.[doi:10.16806/j.cnki.issn.1004-3934.2024.08.017]
YANG Anni,LI Lamei,WANG Lyuya,et al.Research Progress on Exosomes and Lipid Metabolism[J].Advances in Cardiovascular Diseases,2024,(2):753.[doi:10.16806/j.cnki.issn.1004-3934.2024.08.017]